Augnito vs Speke
Two ambient products from companies that were doing this work with people and dictation long before models could. Augnito comes from a transcription business with more than two decades in a national health service estate, and it pairs clinical speech recognition with ambient documentation in one platform, which suits an organisation migrating clinicians from dictation rather than starting fresh. Speke comes from the largest human medical scribe company in the United States, with over a thousand clients behind it, so its automation spectrum runs from a fully drafted note to a human scribe without changing supplier. Neither publishes an accuracy figure. The real question for both is the same one their pure play competitors never have to answer: as the automated tier absorbs more of the volume, what happens to the humans in the service and to the price you were quoted.
- Two decades of clinical speech work behind it, with deep experience in a national health service estate, which is a different operating environment from United States ambulatory practice.
- Speech recognition and ambient documentation in one platform, so an organisation moving clinicians from dictation to ambient capture does not change vendor midway.
- For non United States deployments, the regulatory and procurement experience is already in the company rather than being acquired on your project.
- It comes from the largest human medical scribe company in the United States, serving over a thousand clients, which is an installed base no pure play can match.
- The human tier is the company's core business rather than an option, so a practice can move along the automation spectrum without changing supplier.
- For a health system already using scribe services, this is continuity rather than a new vendor relationship and a new security review.
Side by Side
| Axis | A Augnito |
S Speke |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Both vendors carry a legacy services business alongside the AI product, so the commercial comparison is not like for like against a per clinician software subscription and depends on the mix of automated and human reviewed work. Neither publishes an accuracy figure, model card or evaluation methodology. Neither publishes a rate card.
For any deployment outside the United States, establish which regime governs the product in that market rather than assuming the United States position transfers, and for any deployment inside it, ask what the service level looks like when the automated tier cannot produce an acceptable note.